Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase

Cell Death and Differentiation

Volumn 13, Issue 7, 2006, Pages 1170-1180

  Fujimoto, H ^a   Onishi, N ^a   Kato, N ^a   Takekawa, M ^b,c   Xu, X Z ^a   Kosugi, A ^d   Kondo, T ^e   Imamura, M ^e   Oishi, I ^a   Yoda, A ^a   Minami, Y ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell cycle checkpoint; Chk2 kinase; DNA damage; Phosphorylation; Wip1 phosphatase

Indexed keywords

CHECKPOINT KINASE 2; GLUTATHIONE TRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN WIP1; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTANT; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; WILD TYPE;

AMINO ACIDS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; DNA DAMAGE; HCT116 CELLS; HUMANS; IMMUNOBLOTTING; MUTATION; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SERINE; THREONINE; TUMOR SUPPRESSOR PROTEINS;

EID: 33745206498     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401801     Document Type: Article

References (41)

1. Allen JB, Zhou Z, Siede W, Friedberg EC and Elledge SJ (1994) The SAD1/ RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast. Genes Dev. 8: 2401-2415
2. Murakami H and Okayama H (1995) A kinase from fission yeast responsible for blocking mitosis in S phase. Nature 374: 817-819
3. Oishi I, Sugiyama S, Otani H, Yamamura H, Nishida Y and Minami Y (1998) A novel Drosophila nuclear protein serine/threonine kinase expressed in the germline during its establishment. Mech. Dev. 71: 49-63
4. Oishi I, Iwai K, Kagohashi Y, Fujimoto H, Kariya K, Kataoka T, Sawa H, Okano H, Otani H, Yamamura H and Minami Y (2001) Critical role of Caenorhabditis elegans homologs of Cds1 (Chk2)-related kinases in meiotic recombination. Mol. Cell. Biol. 21: 1329-1335
5. MacQueen AJ and Villeneuve AM (2001) Nuclear reorganization and homologous chromosome pairing during meiotic prophase require C. elegans chk-2. Genes Dev. 15: 1674-1687
6. Matsuoka S, Huang M and Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282: 1893-1897
7. Bartek J, Falck J and Lukas J (2001) CHK2 kinase - a busy messenger. Nat. Rev. Mol. Cell. Biol. 2: 877-886
8. Bartek J and Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429
9. Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H and Chung JH (1999) A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 96: 3745-3750
10. Chaturvedi P, Eng WK, Zhu Y, Mattem MR, Mishra R, Hurle MR, Zhang X, Annan RS, Lu Q, Faucette LF, Scott GF, Li X, Carr SA, Johnson RK, Winkler JD and Zhou BB (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18: 4047-4054
11. Melchionna R, Chen XB, Blasina A and McGowan CH (2000) Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol. 2: 762-765
12. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K and Elledge SJ (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97: 10389-10394
13. Ahn JY, Schwarz JK, Piwnica-Worms H and Canman CE (2000) Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60: 5934-5936
14. Blasina A, de Weyer IV, Laus MC, Luyten WH, Parker AE and McGowan CH (1999) A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr. Biol. 9: 1-10
15. Chehab NH, Malikzay A, Appel M and Halazonetis TO (2000) Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14: 278-288
16. Shieh SY, Ahn J, Tamai K, Taya Y and Prives C (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14: 289-300
17. Lee JS, Collins KM, Brown AL, Lee CH and Chung JH (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404: 201-204
18. Yang S, Kuo C, Bisi JE and Kim MK (2002) PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat. Cell Biol. 4: 865-870
19. Stevens C, Smith L and La Thangue NB (2003) Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5: 401-409
20. den Elzen NR and O'Connell MJ (2004) Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1. EMBO J. 23: 908-918
21. Leroy C, Lee SE, Vaze MB, Ochsenbien F, Guerois R, Haber JE and Marsolier-Kergoat MC (2003) PP2C phosphatases Ptc2 and Ptc3 are required for DNA checkpoint inactivation after a double-strand break. Mol. Cell 11: 827-835
22. Cohen P (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58: 453-508
23. Takekawa M, Maeda T and Saito H (1998) Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 17: 4744-4752
24. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y and Imai K (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19: 6517-6526
25. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, Vande Woude GF, O'Connor PM and Appella E (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 94: 6048-6053
26. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA, Ambrosino C, Sauter G, Nebreda AR, Anderson CW, Kallioniemi A, Fornace Jr AJ and Appella E (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppresser activity. Nat. Genet. 31: 210-215
27. Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW and Powers S (2002) Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat. Genet. 31: 133-134
28. Saito-Ohara F, Imoto I, Inoue J, Hosoi H, Nakagawara A, Sugimoto T and Inazawa J (2003) PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 63: 1876-1883
29. Hirasawa A, Saito-Ohara F, Inoue J, Aoki D, Susumu N, Yokoyama T, Nozawa S, Inazawa J and Imoto I (2003) Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin. Cancer Res. 9: 1995-2004
30. Lu X, Bocangel D, Nannenga B, Yamaguchi H, Appella E and Donehower LA (2004) The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol. Cell 15: 621-634
31. Ward IM, Wu X and Chen J (2001) Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J. Biol. Chem. 276: 47755-47758
32. Xu X, Tsvetkov LM and Stern DF (2002) Chk2 activation and phosphorylation-dependent oligomerization. Mol. Cell. Biol. 22: 4419-4432
33. Ahn JY, Li X, Davis HL and Canman CE (2002) Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain. J. Biol. Chem. 277: 19389-19395
34. Schwarz JK, Lovly CM and Piwnica-Worms H (2003) Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol. Cancer Res. 1: 598-609
35. Wu X and Chen J (2003) Autophosphorylation of Chk2 at serine-516 is required for radiation-induced apoptosis. J. Biol. Chem. 278: 36163-36168
36. Choi J, Nannenga B, Demidov ON, Bulavin DV, Cooney A, Brayton C, Zhang Y, Mbawuike IN, Bradley A, Appella E and Donehower LA (2002) Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 22: 1094-1105
37. Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE and Haber DA (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286: 2528-2531
38. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E and Fornace Jr AJ (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36: 343-350
39. Harrison M, Li J, Degenhardt Y, Hoey T and Powers S (2004) Wip1-deficient mice are resistant to common cancer genes. Trends Mol. Med. 10: 359-361
40. Lu X, Nannenga B and Donehower LA (2005) PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 19: 1162-1174
41. Yamaguchi H, Minopoli G, Demidov ON, Chatterjee DK, Anderson CW, Durell SR and Appella E (2005) Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. Biochemistry 44: 5285-5294